Background: (6R)-5,6,7,8-tetrahydrobiopterin (BH4) deficiencies are rare inherited defects of synthesis or regeneration of BH4. Due to the resulting hyperphenylalaninemia (HPA), some of them are detected by newborn screening and require the assessment of the pattern of neopterin (Neo) and biopterin (Bio) excretion in urine to be confirmed. Aim of present study was to develop a method for the measurement of these diagnostic biomarkers in dried blood spot (DBS). Methods: After DBS extraction, samples were filtered and injected into the UPLC column coupled with a tandem mass spectrometer working in positive electrospray ionization. Results: The chromatographic separation was accomplished in 6 min. The LoQ was 0.57 and 1.45 nmol/l of blood for Neo and Bio respectively and the response was linear over the range 0–100 nmol/l of blood. The within- and between-day imprecision was b6.4 and 10.8% respectively. Reference ranges for newborns, infants and children/ adult were established. The method was tested in 11 patients affected by BH4 defects. Conclusions: The assessment of Neo and Bio in DBS is reliable and sensitive and may be proposed as a second tier test for the newborns with hyperphenylalaninemia (HPA) as well as a new potential diagnostic tool for symptomatic subjects with BH4 deficiencies

Development of a new UPLC-ESI-MS/MS method for the determination of biopterin and neopterin in dried blood spot / Santagata, Silvia; Di Carlo, Emanuele; Carducci, Carla; Leuzzi, Vincenzo; Angeloni, Antonio; Carducci, Claudia. - In: CLINICA CHIMICA ACTA. - ISSN 0009-8981. - STAMPA. - 466:(2017), pp. 145-151. [10.1016/j.cca.2017.01.019]

Development of a new UPLC-ESI-MS/MS method for the determination of biopterin and neopterin in dried blood spot

SANTAGATA, SILVIA;Di Carlo, Emanuele;CARDUCCI, Carla;LEUZZI, Vincenzo;ANGELONI, Antonio;CARDUCCI, Claudia
2017

Abstract

Background: (6R)-5,6,7,8-tetrahydrobiopterin (BH4) deficiencies are rare inherited defects of synthesis or regeneration of BH4. Due to the resulting hyperphenylalaninemia (HPA), some of them are detected by newborn screening and require the assessment of the pattern of neopterin (Neo) and biopterin (Bio) excretion in urine to be confirmed. Aim of present study was to develop a method for the measurement of these diagnostic biomarkers in dried blood spot (DBS). Methods: After DBS extraction, samples were filtered and injected into the UPLC column coupled with a tandem mass spectrometer working in positive electrospray ionization. Results: The chromatographic separation was accomplished in 6 min. The LoQ was 0.57 and 1.45 nmol/l of blood for Neo and Bio respectively and the response was linear over the range 0–100 nmol/l of blood. The within- and between-day imprecision was b6.4 and 10.8% respectively. Reference ranges for newborns, infants and children/ adult were established. The method was tested in 11 patients affected by BH4 defects. Conclusions: The assessment of Neo and Bio in DBS is reliable and sensitive and may be proposed as a second tier test for the newborns with hyperphenylalaninemia (HPA) as well as a new potential diagnostic tool for symptomatic subjects with BH4 deficiencies
2017
BH4 deficiencies; Biopterin; Dried blood spot; Neopterin; Tandem mass spectrometry; Adolescent; Biopterin; Child; Child, Preschool; Chromatography, Liquid; Dried Blood Spot Testing; Humans; Infant; Infant, Newborn; Neonatal Screening; Neopterin; Phenylketonurias; Reference Values; Tandem Mass Spectrometry; Young Adult; Biochemistry; Clinical Biochemistry; Biochemistry (medical)
01 Pubblicazione su rivista::01a Articolo in rivista
Development of a new UPLC-ESI-MS/MS method for the determination of biopterin and neopterin in dried blood spot / Santagata, Silvia; Di Carlo, Emanuele; Carducci, Carla; Leuzzi, Vincenzo; Angeloni, Antonio; Carducci, Claudia. - In: CLINICA CHIMICA ACTA. - ISSN 0009-8981. - STAMPA. - 466:(2017), pp. 145-151. [10.1016/j.cca.2017.01.019]
File allegati a questo prodotto
File Dimensione Formato  
Santagata_Development-new_2017.pdf

solo utenti autorizzati

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 946.95 kB
Formato Adobe PDF
946.95 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/953871
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 9
social impact